AFP Stock Overview
Engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for AFP from our risk checks.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
AFT Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NZ$2.37 |
| 52 Week High | NZ$3.16 |
| 52 Week Low | NZ$2.15 |
| Beta | 0.34 |
| 1 Month Change | -3.27% |
| 3 Month Change | -5.20% |
| 1 Year Change | -3.66% |
| 3 Year Change | -25.94% |
| 5 Year Change | -42.48% |
| Change since IPO | -19.66% |
Recent News & Updates
Recent updates
Shareholder Returns
| AFP | AU Pharmaceuticals | AU Market | |
|---|---|---|---|
| 7D | -3.3% | -0.8% | 0.6% |
| 1Y | -3.7% | -26.7% | 3.7% |
Return vs Industry: AFP exceeded the Australian Pharmaceuticals industry which returned -26.7% over the past year.
Return vs Market: AFP underperformed the Australian Market which returned 3.7% over the past year.
Price Volatility
| AFP volatility | |
|---|---|
| AFP Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 11.5% |
| Market Average Movement | 9.5% |
| 10% most volatile stocks in AU Market | 16.8% |
| 10% least volatile stocks in AU Market | 4.1% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine AFP's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 110 | Hartley Atkinson | www.aftpharm.com |
AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, gastrointestinal, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, vitamins, and supplements, as well as other products. The company has collaboration with Belgium’s Hyloris Pharmaceuticals to develop a novel innovative injectable iron deficiency therapy.
AFT Pharmaceuticals Limited Fundamentals Summary
| AFP fundamental statistics | |
|---|---|
| Market cap | AU$255.02m |
| Earnings (TTM) | AU$10.69m |
| Revenue (TTM) | AU$182.86m |
Is AFP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AFP income statement (TTM) | |
|---|---|
| Revenue | NZ$198.51m |
| Cost of Revenue | NZ$109.98m |
| Gross Profit | NZ$88.54m |
| Other Expenses | NZ$76.93m |
| Earnings | NZ$11.61m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
May 21, 2025
| Earnings per share (EPS) | 0.11 |
| Gross Margin | 44.60% |
| Net Profit Margin | 5.85% |
| Debt/Equity Ratio | 36.0% |
How did AFP perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/20 15:19 |
| End of Day Share Price | 2025/05/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
AFT Pharmaceuticals Limited is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Hester | Bell Potter |
| Jack Crowley | Credit Suisse |
| Soo Romanoff | Edison Investment Research |